ANTI-IL-1B ANTIBODIES

The present invention relates to anti-IL-1B binding compounds, in particular new optimized anti-IL-1B antibodies and therapeutic and diagnostic methods and compositions for using the same. La présente invention concerne des composés de liaison anti-IL-1B, en particulier des anticorps anti-IL-1B opti...

Full description

Saved in:
Bibliographic Details
Main Authors SEELIGER, DANIEL, WEIGLE, BERND, WYATT, DAVID MICHAEL, FUCHS, KLAUS, PARK, JOHN EDWARD, GUPTA, PANKAJ, PETER, DANIEL, FISCHER, PETER, CANADA, KEITH A
Format Patent
LanguageEnglish
French
Published 21.01.2016
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to anti-IL-1B binding compounds, in particular new optimized anti-IL-1B antibodies and therapeutic and diagnostic methods and compositions for using the same. La présente invention concerne des composés de liaison anti-IL-1B, en particulier des anticorps anti-IL-1B optimisés inédits, ainsi que des méthodes thérapeutiques et diagnostiques et des compositions permettant de les utiliser.
Bibliography:Application Number: WO2015EP65979